* Regeneron Acquires 23andMe Assets
Pharmaceutical giant Regeneron won a bankruptcy auction to acquire most of 23andMe’s assets for $256 million, including its Personal Genome Service, Total Health, Research Services, and biobank. This deal will boost Regeneron’s genomics-driven drug discovery using 23andMe’s DNA data. The transaction, pending court and regulatory approval, is expected to close ...
去小宇宙查看完整单集简介前往小宇宙评论区与主播互动